Acrospire Investment Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,147
Closed -$30K 1268
2017
Q2
$30K Sell
1,147
-1,500
-57% -$40K 0.03% 1292
2017
Q1
$72K Sell
2,647
-9,518
-78% -$243K 0.06% 596
2016
Q4
$300K Buy
12,165
+2,009
+20% +$42.3K 0.12% 150
2016
Q3
$230K Buy
10,156
+300
+3% +$6.55K 0.15% 94
2016
Q2
$186K Buy
9,856
+7,200
+271% +$150K 0.14% 110
2016
Q1
$69K Buy
+2,656
New +$61.5K 0.05% 646

Other funds holding TBI

Acrospire Investment Management's TBI Position: Q3 2017 in Review

Acrospire Investment Management sold out of Trueblue (TBI) in Q3 2017, closing a stake of 1,147 shares — an estimated $30K sold.

Acrospire Investment Management first reported a position in TBI in Q1 2016 and held it in 6 quarters. The position peaked at $300K in Q4 2016. 191 funds tracked by Wall St. Rank hold TBI as of Q3 2017.

  • Acrospire Investment Management reported no remaining Trueblue position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,147 Trueblue shares in Q3 2017, an estimated $30K.
  • Acrospire Investment Management first reported a position in Trueblue in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Trueblue position peaked at $300K in Q4 2016.
  • 191 funds tracked by Wall St. Rank held Trueblue as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.